Global Integrated Drug Containment and Delivery Solution Market Growth 2025-2031

Publication ID:

LPI06250435

Publication Date:

June 2, 2025

Pages:

117

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global Integrated Drug Containment and Delivery Solution market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
The 鈥淚ntegrated Drug Containment and Delivery Solution Industry Forecast鈥� looks at past sales and reviews total world Integrated Drug Containment and Delivery Solution sales in 2024, providing a comprehensive analysis by region and market sector of projected Integrated Drug Containment and Delivery Solution sales for 2025 through 2031. With Integrated Drug Containment and Delivery Solution sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Integrated Drug Containment and Delivery Solution industry.
This Insight Report provides a comprehensive analysis of the global Integrated Drug Containment and Delivery Solution landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Integrated Drug Containment and Delivery Solution portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Integrated Drug Containment and Delivery Solution market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Integrated Drug Containment and Delivery Solution and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Integrated Drug Containment and Delivery Solution.
This report presents a comprehensive overview, market shares, and growth opportunities of Integrated Drug Containment and Delivery Solution market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Pre-fillable Syringes
Auto-injectors
Inhalers
Nasal Sprays
Transdermal Patches
Others
Segmentation by Application:
Hospital
Clinic
Ambulatory Surgery Center
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
BD
Gerresheimer AG
West Pharmaceutical Services, Inc
Schott AG
AptarGroup, Inc
Catalent, Inc
Stevanato Group
Nipro Corporation
Owen Mumford
Ypsomed AG
MedPro Inc
Key Questions Addressed in this Report
What is the 10-year outlook for the global Integrated Drug Containment and Delivery Solution market?
What factors are driving Integrated Drug Containment and Delivery Solution market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Integrated Drug Containment and Delivery Solution market opportunities vary by end market size?
How does Integrated Drug Containment and Delivery Solution break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Integrated Drug Containment and Delivery Solution Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Integrated Drug Containment and Delivery Solution by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Integrated Drug Containment and Delivery Solution by Country/Region, 2020, 2024 & 2031
2.2 Integrated Drug Containment and Delivery Solution Segment by Type
2.2.1 Pre-fillable Syringes
2.2.2 Auto-injectors
2.2.3 Inhalers
2.2.4 Nasal Sprays
2.2.5 Transdermal Patches
2.2.6 Others
2.3 Integrated Drug Containment and Delivery Solution Sales by Type
2.3.1 Global Integrated Drug Containment and Delivery Solution Sales Market Share by Type (2020-2025)
2.3.2 Global Integrated Drug Containment and Delivery Solution Revenue and Market Share by Type (2020-2025)
2.3.3 Global Integrated Drug Containment and Delivery Solution Sale Price by Type (2020-2025)
2.4 Integrated Drug Containment and Delivery Solution Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Ambulatory Surgery Center
2.5 Integrated Drug Containment and Delivery Solution Sales by Application
2.5.1 Global Integrated Drug Containment and Delivery Solution Sale Market Share by Application (2020-2025)
2.5.2 Global Integrated Drug Containment and Delivery Solution Revenue and Market Share by Application (2020-2025)
2.5.3 Global Integrated Drug Containment and Delivery Solution Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Integrated Drug Containment and Delivery Solution Breakdown Data by Company
3.1.1 Global Integrated Drug Containment and Delivery Solution Annual Sales by Company (2020-2025)
3.1.2 Global Integrated Drug Containment and Delivery Solution Sales Market Share by Company (2020-2025)
3.2 Global Integrated Drug Containment and Delivery Solution Annual Revenue by Company (2020-2025)
3.2.1 Global Integrated Drug Containment and Delivery Solution Revenue by Company (2020-2025)
3.2.2 Global Integrated Drug Containment and Delivery Solution Revenue Market Share by Company (2020-2025)
3.3 Global Integrated Drug Containment and Delivery Solution Sale Price by Company
3.4 Key Manufacturers Integrated Drug Containment and Delivery Solution Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Integrated Drug Containment and Delivery Solution Product Location Distribution
3.4.2 Players Integrated Drug Containment and Delivery Solution Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Integrated Drug Containment and Delivery Solution by Geographic Region
4.1 World Historic Integrated Drug Containment and Delivery Solution Market Size by Geographic Region (2020-2025)
4.1.1 Global Integrated Drug Containment and Delivery Solution Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Integrated Drug Containment and Delivery Solution Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Integrated Drug Containment and Delivery Solution Market Size by Country/Region (2020-2025)
4.2.1 Global Integrated Drug Containment and Delivery Solution Annual Sales by Country/Region (2020-2025)
4.2.2 Global Integrated Drug Containment and Delivery Solution Annual Revenue by Country/Region (2020-2025)
4.3 Americas Integrated Drug Containment and Delivery Solution Sales Growth
4.4 APAC Integrated Drug Containment and Delivery Solution Sales Growth
4.5 Europe Integrated Drug Containment and Delivery Solution Sales Growth
4.6 Middle East & Africa Integrated Drug Containment and Delivery Solution Sales Growth
5 Americas
5.1 Americas Integrated Drug Containment and Delivery Solution Sales by Country
5.1.1 Americas Integrated Drug Containment and Delivery Solution Sales by Country (2020-2025)
5.1.2 Americas Integrated Drug Containment and Delivery Solution Revenue by Country (2020-2025)
5.2 Americas Integrated Drug Containment and Delivery Solution Sales by Type (2020-2025)
5.3 Americas Integrated Drug Containment and Delivery Solution Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Integrated Drug Containment and Delivery Solution Sales by Region
6.1.1 APAC Integrated Drug Containment and Delivery Solution Sales by Region (2020-2025)
6.1.2 APAC Integrated Drug Containment and Delivery Solution Revenue by Region (2020-2025)
6.2 APAC Integrated Drug Containment and Delivery Solution Sales by Type (2020-2025)
6.3 APAC Integrated Drug Containment and Delivery Solution Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Integrated Drug Containment and Delivery Solution by Country
7.1.1 Europe Integrated Drug Containment and Delivery Solution Sales by Country (2020-2025)
7.1.2 Europe Integrated Drug Containment and Delivery Solution Revenue by Country (2020-2025)
7.2 Europe Integrated Drug Containment and Delivery Solution Sales by Type (2020-2025)
7.3 Europe Integrated Drug Containment and Delivery Solution Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Integrated Drug Containment and Delivery Solution by Country
8.1.1 Middle East & Africa Integrated Drug Containment and Delivery Solution Sales by Country (2020-2025)
8.1.2 Middle East & Africa Integrated Drug Containment and Delivery Solution Revenue by Country (2020-2025)
8.2 Middle East & Africa Integrated Drug Containment and Delivery Solution Sales by Type (2020-2025)
8.3 Middle East & Africa Integrated Drug Containment and Delivery Solution Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Integrated Drug Containment and Delivery Solution
10.3 Manufacturing Process Analysis of Integrated Drug Containment and Delivery Solution
10.4 Industry Chain Structure of Integrated Drug Containment and Delivery Solution
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Integrated Drug Containment and Delivery Solution Distributors
11.3 Integrated Drug Containment and Delivery Solution Customer
12 World Forecast Review for Integrated Drug Containment and Delivery Solution by Geographic Region
12.1 Global Integrated Drug Containment and Delivery Solution Market Size Forecast by Region
12.1.1 Global Integrated Drug Containment and Delivery Solution Forecast by Region (2026-2031)
12.1.2 Global Integrated Drug Containment and Delivery Solution Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Integrated Drug Containment and Delivery Solution Forecast by Type (2026-2031)
12.7 Global Integrated Drug Containment and Delivery Solution Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 BD
13.1.1 BD Company Information
13.1.2 BD Integrated Drug Containment and Delivery Solution Product Portfolios and Specifications
13.1.3 BD Integrated Drug Containment and Delivery Solution Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 BD Main Business Overview
13.1.5 BD Latest Developments
13.2 Gerresheimer AG
13.2.1 Gerresheimer AG Company Information
13.2.2 Gerresheimer AG Integrated Drug Containment and Delivery Solution Product Portfolios and Specifications
13.2.3 Gerresheimer AG Integrated Drug Containment and Delivery Solution Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Gerresheimer AG Main Business Overview
13.2.5 Gerresheimer AG Latest Developments
13.3 West Pharmaceutical Services, Inc
13.3.1 West Pharmaceutical Services, Inc Company Information
13.3.2 West Pharmaceutical Services, Inc Integrated Drug Containment and Delivery Solution Product Portfolios and Specifications
13.3.3 West Pharmaceutical Services, Inc Integrated Drug Containment and Delivery Solution Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 West Pharmaceutical Services, Inc Main Business Overview
13.3.5 West Pharmaceutical Services, Inc Latest Developments
13.4 Schott AG
13.4.1 Schott AG Company Information
13.4.2 Schott AG Integrated Drug Containment and Delivery Solution Product Portfolios and Specifications
13.4.3 Schott AG Integrated Drug Containment and Delivery Solution Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Schott AG Main Business Overview
13.4.5 Schott AG Latest Developments
13.5 AptarGroup, Inc
13.5.1 AptarGroup, Inc Company Information
13.5.2 AptarGroup, Inc Integrated Drug Containment and Delivery Solution Product Portfolios and Specifications
13.5.3 AptarGroup, Inc Integrated Drug Containment and Delivery Solution Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 AptarGroup, Inc Main Business Overview
13.5.5 AptarGroup, Inc Latest Developments
13.6 Catalent, Inc
13.6.1 Catalent, Inc Company Information
13.6.2 Catalent, Inc Integrated Drug Containment and Delivery Solution Product Portfolios and Specifications
13.6.3 Catalent, Inc Integrated Drug Containment and Delivery Solution Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Catalent, Inc Main Business Overview
13.6.5 Catalent, Inc Latest Developments
13.7 Stevanato Group
13.7.1 Stevanato Group Company Information
13.7.2 Stevanato Group Integrated Drug Containment and Delivery Solution Product Portfolios and Specifications
13.7.3 Stevanato Group Integrated Drug Containment and Delivery Solution Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Stevanato Group Main Business Overview
13.7.5 Stevanato Group Latest Developments
13.8 Nipro Corporation
13.8.1 Nipro Corporation Company Information
13.8.2 Nipro Corporation Integrated Drug Containment and Delivery Solution Product Portfolios and Specifications
13.8.3 Nipro Corporation Integrated Drug Containment and Delivery Solution Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Nipro Corporation Main Business Overview
13.8.5 Nipro Corporation Latest Developments
13.9 Owen Mumford
13.9.1 Owen Mumford Company Information
13.9.2 Owen Mumford Integrated Drug Containment and Delivery Solution Product Portfolios and Specifications
13.9.3 Owen Mumford Integrated Drug Containment and Delivery Solution Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Owen Mumford Main Business Overview
13.9.5 Owen Mumford Latest Developments
13.10 Ypsomed AG
13.10.1 Ypsomed AG Company Information
13.10.2 Ypsomed AG Integrated Drug Containment and Delivery Solution Product Portfolios and Specifications
13.10.3 Ypsomed AG Integrated Drug Containment and Delivery Solution Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Ypsomed AG Main Business Overview
13.10.5 Ypsomed AG Latest Developments
13.11 MedPro Inc
13.11.1 MedPro Inc Company Information
13.11.2 MedPro Inc Integrated Drug Containment and Delivery Solution Product Portfolios and Specifications
13.11.3 MedPro Inc Integrated Drug Containment and Delivery Solution Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 MedPro Inc Main Business Overview
13.11.5 MedPro Inc Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂